Agilent Modernizes IVD Study Conduct with Speed and Data Confidence
"We came from a purely paper-based background, and we were looking for an electronic system that would help us be efficient and compliant"
Learn how Agilent is adapting their operations and technology to keep pace with rapid change in the IVD space. Gregory Cherryholmes, senior clinical affairs scientist, Agilent Technologies, shares how moving away from manual processes has paved the way for more complex trials.